etravirine has been researched along with Immune Reconstitution Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, A; Asmuth, DM; Hayes, T; Knight, TH; Ma, ZM; Mann, S; Melcher, GP; Miller, CJ; Pollard, RB; Troia-Cancio, P; Yotter, T | 1 |
1 trial(s) available for etravirine and Immune Reconstitution Disease
| Article | Year |
|---|---|
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Endoscopy; Female; Gastrointestinal Tract; Humans; Immune Reconstitution Inflammatory Syndrome; Immunohistochemistry; Lymphocyte Activation; Lymphoid Tissue; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load | 2012 |